Showing results (171-180 of 329) with videos related to

Sort By:
Pageof 33
Journal of Pediatric Hematology/Oncology|March 7, 2002
Thrombocytopenia absent corpus callosum syndrome: third case of a distinct clinical entityY Khabbaze, G Karayalcin, C Paley, et al.
AJR. American Journal of Roentgenology|September 1, 1983
Evaluation of the post-coronary artery bypass patient by myocardial perfusion scintigraphy and computed tomographyB L Engelstad, S Wagner, R Herfkens, et al.
Neuropathology and Applied Neurobiology|June 6, 2003
Frontotemporal and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALSE H Bigio, A M Lipton, C L White, et al.
Brain Research|July 23, 1999
Systemically administered alpha-melanocyte-stimulating peptides inhibit NF-kappaB activation in experimental brain inflammationT Ichiyama, T Sakai, A Catania, et al.
Journal of the American College of Cardiology|September 1, 1993
Ultrasonic backscatter system for automated on-line endocardial boundary detection: evaluation by ultrafast computed tomographyR H Marcus, J Bednarz, R Coulden, et al.
Peptides|January 1, 1996
The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitroA Catania, N Rajora, F Capsoni, et al.
Blood|September 1, 1985
Reduction of lethal graft-versus-host disease: transplantation of cultured murine bone marrow across minor histocompatibility differencesP Mauch, J M Lipton, B L Hamilton, et al.
The American Journal of Physiology|March 1, 1988
C-reactive protein, leukocytes, and fever after central IL 1 and alpha-MSH in aged rabbitsT K Dao, R C Bell, J Feng, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 15, 1997
alpha-MSH modulates local and circulating tumor necrosis factor-alpha in experimental brain inflammationN Rajora, G Boccoli, D Burns, et al.
Environmental Health Perspectives|July 16, 2002
Environmental pollutants and disease in American children: estimates of morbidity, mortality, and costs for lead poisoning, asthma, cancer, and developmental disabilitiesPhilip J Landrigan, Clyde B Schechter, Jeffrey M Lipton, et al.
Pageof 33